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ABSTRACT 
 
 Cardiovascular disease is the leading cause of mortality in the world.  Cardiac 
tissue engineering promises to replace damaged organs and tissues with biologically 
compatible engineered substitutes.  Micro- and nanotechnologies have proven to be 
effective to address current challenges in tissue engineering and regenerative medicine.  
A principle approach in tissue engineering is the integration of innovative biomaterials 
with micro- and nanofabrication techniques to generate constructs that recapitulate the in 
vivo cellular microenvironments.      
 In this study, highly organized three-dimensional (3D) cardiac tissue constructs in 
carbon nanotube (CNT) embedded gelatin methacrylate (GelMA) were generated using 
micropatterning techniques.  Neonatal rat ventricular cardiomyocytes (NRVMs) and 
cardiac fibroblasts (CFs) were used as the primary cardiac cell types to be encapsulated in 
the three-dimensional tissue constructs.  The resulting cardiac constructs in CNT-GelMA 
vi 
 
hybrid hydrogels from various methods showed enhanced cell viability and higher 
spontaneous synchronous beating rates, compared to those in pristine GelMA hydrogels. 
 Further studies are necessary to determine the efficacy of micropatterned 3D 
cardiac tissue constructs in CNT-GelMA hybrid hydrogels for in vitro studies and 
therapeutic purposes. 
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INTRODUCTION 
 
 Cardiovascular disease remains the leading cause of mortality in the world with 
an estimated 17 million deaths every year.  In the United States, an estimated 82.6 million 
adults have one or more types of the disease (Roger et al., 2012) and approximately 
600,000 people die of cardiovascular disease each year (Kochanek et al., 2011).  
Myocardial infarction leads to significant loss of functioning cardiomyocytes that 
ultimately results in pathological heart remodeling and heart failure (Eschenhagen et al., 
2012; Liau et al., 2012;).  It is estimated that approximately 1.3 million Americans suffer 
from myocardial infarction each year and approximately 5.7 million Americans 
experience heart failure (Roger et al., 2012). 
The rapidly advancing fields of tissue engineering and regenerative medicine 
holds great potential in the future replacement of damaged organs and tissues with 
biologically relevant engineered substitutes that have the potential to restore normal 
function (Harrison and Atala, 2007).  Nanotechnology is a new emerging field within 
tissue engineering and regenerative medicine that constructs structures and systems with 
materials of 1-100nm.  There are many nanomaterials that are currently being studied, 
such as iron oxide superparamagnetic nanoparticles and quantum dots (Bulte et al., 1999; 
Bulte et al., 2001; Harrison and Atala, 2007).  Living cells seeded in highly porous three-
dimensional (3D) polymer scaffolds provide biomechanical supports for the cells to 
facilitate formation of structural and functional tissue (Langer and Vacanti, 1993). 
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Several research groups have demonstrated that cardiomyocytes from neonatal 
rats and embryonic chicks may be used to reconstruct 3D cardiac constructs with 
collagen gels, collagen fibers, collagen sponges, polyglycolic acid, and alginate (Chan et 
al., 2013).  With the classical cell-scaffold approach, rings of cardiac muscles were mixed 
with neonatal rat cardiomyocytes in collagen gel and casted in a ring template to grow 
engineered heart tissues (Eschenhagen et al., 1997).  Although the stretched engineered 
heart tissues exhibited better cardiac tissue/matrix ratio, improved contractile function, 
and a high degree of cardiac myocyte differentiation, the engineered heart tissues exerted 
significantly lower forces compared to the native myocardium (Chan et al., 2013; 
Eschenhagen et al., 1997).  Also, as the cell sheet engineering approach, neonatal rat 
cardiomyocytes (NRVMs) were cultured on poly-(N-isopropylacrylamide) (PIPAAm), a 
temperature-responsive polymer (Chan et al., 2013; Shimizu et al., 2002).  PIPAAm 
becomes slightly hydrophobic and adhesive at 37 o and reversibly becomes hydrophilic 
taking on a non-adhesive state due to rapid hydration and cell swelling when reached 
below 32o C (Chan et al., 2013).  Such mechanical characteristics allow the cell 
monolayers to be released without enzymatic digestion that may disrupt cell-cell 
junctions and adhesive proteins.  The cell sheets were layered on top of each other up to 
four layers to allow them to fuse together and form functional tissue.  The sheets beat 
synchronously when electrically stimulated (Chan et al., 2013; Shimizu et al., 2002).  
Also, the grafted sheets of two layers of cardiac cell sheets that were overlaid and 
transplanted onto the infarcted region of a rat heart showed simultaneous contractions 
(Chan et al., 2013; Shimizu et al., 2002).  Although the measured conductance velocity of 
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the infarcted myocardium was reduced by almost 50% in the fiber orientation compared 
to the normal myocardium, the initial conductance velocity of 100cm/s was restored by 
week 4 (Chan et al., 2013; Furuta et al., 2006).  Although the aforementioned approaches 
seem effective in some contexts, there are many challenges in developing functional 
bioengineered cardiac tissue for therapeutic purposes.  Seeding cells in porous 3D 
scaffolds often does not result in sufficient tissue functional characteristics of normal 
myocardial tissue, and such tissues show weak cellular integrity, short duration of 
contractility, and inhomogeneous cell seeding (Chan et al., 2013; Vunjak-Novakovic, 
2006).  Although scaffolds are adequate base materials for cell growth, they are not ideal 
since they prevent the propagation of electrical signals and the subtypes of myocytes, 
such as pacemaking, atrial, ventricular, and Purkinje cells exhibit different functional 
characteristics (Chan et al., 2013). 
It is crucial to develop biomimetic extracellular matrices (ECMs) in myocardial 
tissue engineering (Chien et al., 2008).  ECM is composed of networks of protein and 
polysaccharide-based nanofibers which provide mechanical support and signaling cues to 
cells (Discher et al., 2005; Engler et al., 2006; Shin et al., 2012).  The interactions 
between the cells and the ECM have been studied on two-dimensional (2D) substrates 
(Lutolf et al., 2009; Park et al., 2011; Shin et al., 2012). 
There are numerous applications of micro-scale tissue engineering that showed 
precisely controlled co-culture conditions and cell-cell interactions (Du et al., 2008; 
Tsang et al., 2007).  In order to generate 3D ECM constructs, hydrogels with high water 
content and controllable biodegradability have been widely used (Shin et al., 2012).  
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Moreover, their easily modifiable physical and chemical properties and high permeability 
for transporting nutrients and metabolites are great for cell encapsulation (Bienaime et al., 
2003; Chia et al., 2000; Drury & Mooney, 2003; Peppas et al., 2006; Shin et al., 2012; 
Uludag et al., 2000).  However, some hydrogels have poor mechanical properties, cell 
binding and viability or the inability to control the microarchitecture.  Other hydrogels, 
such as polyethylene glycol (PEG) or hyaluronic acid (HA) have stronger mechanical 
properties and great cell viability of those encapsulated (Brigham et al., 2009; Du et al., 
2008; Khademhosseini et al., 2006), however, they lack cell-responsive features.  Thus, 
such hydrogels significantly limit the ability of the cells to proliferate, elongate, migrate, 
and organize into higher order structures (Nichol et al., 2010).  In order to closely mimic 
the natural properties of specific tissue types, such as brain, muscle, bone, and cardiac, it 
is critical to control the mechanical properties of hydrogels in developing 3D ECM 
(Kumachev et al., 2011; Shin et al., 2012).  Although many approaches to generate highly 
cross-linked 3D hydrogels have been suggested to improve cell binding and spreading, 
limited cell movements and organization are observed due to lack of cells to degrade the 
hydrogel (Engler et al., 2006; Hutson et al., 2011; Nichol et al., 2010; Patel et al., 2005; 
Shin et al., 2012). 
Gelatin methacrylate (GelMA) is a photopolymerizable hydrogel with modified 
natural ECM components (Van DenBulcke et al., 2000).  Gelatin is denatured collagen 
that retains natural cell binding motifs (Galis & Khatri., 2002; Nichol et al., 2010; Van 
den Steen et al., 2002).  The methacrylate groups attached to the amine-side groups of 
gelatin allows GelMA to be light polymerizable into a hydrogel that is stable at 37o 
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(Nichol et al., 2010).  GelMA may be used for various applications through modification 
of the methacrylation degree and gel concentration and the pattern fidelity and resolution 
of GelMA were high (Nichol et al., 2010).  Additionally, GelMA micropatterns can be 
used to create cellular micropatterns for 3D micro-fabrication, such as endothelialized 
microvasculature (Nichol et al., 2010). 
Conventionally bioengineered cardiac tissues have not been successful at 
recapitulating the organizational structures and functionality of the native myocardium.  
Thus, a novel approach to add carbon nanotubes (CNTs) and gelatin methacrylate 
(GelMA) to create a functional and biocompatible cardiac constructs with enhanced 
electrophysiological and mechanical properties and improved cell adhesion, viability, and 
organization is significant (Shin et al., 2013).  The mechanical properties of GelMA were 
enhanced by CNTs by creating porous hydrogels with tunable mechanical properties with 
increased elastic modulus (Shin et al., 2012).  Furthermore, the cardiac tissues in CNT-
GelMA hybrid hydrogels exhibited increased spontaneous beating rates and lowered 
excitation thresholds and protective effects against cardio-inhibitory and cardio-toxic 
drugs (Shin et al., 2013).   
CNTs are one of the nanomaterials with great potential for many different uses.  
Carbon-based nanotechnology has been rapidly developing and is suitable for many 
biomedical uses, such as biosensors, cell delivery agents, and as supporting structures for 
tissue engineering scaffolds (Chen et al., 2003; Harrison and Atala, 2007; Hone and Kam, 
2007), since the nanomaterials were discovered by Iijima in 1991 (Iijima, 1991).  
Additionally, since the year of 2000, more than double the amount of articles related to 
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carbon nanotubes for biomedical applications have been published (Harrison and Atala, 
2007).   
Carbon nanotubes are cylindrical carbon tubes with nanometer diameters and 
longer lengths, thus adopting a high aspect ratio and a wider range of chemical, 
mechanical, electrical, and thermal properties (Harrison and Atala, 2007; Park et al., 
2004; Tasis et al., 2006).  They are also extremely biocompatible (Cellot et al., 2009) 
with intrinsically large surface areas (Cellot et al., 2009).  There are two types of carbon 
nanotubes; single-walled carbon nanotube (SWNTs) or multi-walled carbon nanotube 
(MWNTs).  CNTs are mainly used to track and label cells, sense cellular behavior, and 
augment cellular behavior and enhance tissue matrices (Harrison and Atala, 2007).  
However, the possible cytotoxicity of carbon nanotubes raises a concern for their 
application in therapeutic purposes.  Although the cytotoxicity of carbon nanotubes 
remains inconclusive, new approaches to mitigate the cytotoxicity are currently being 
developed.  When cells are cultured with carbon nanotubes functionalized with 
glycopolymers, the cells appear similar to the cells grown in the absence of carbon 
nanotubes (Reynolds et al., 2000).   
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Specific Aims 
 In order to create cardiovascular constructs that recapitulate the in vivo cellular 
microenvironments, many attempts have been made to integrate innovative biomaterials 
with micro and nano-fabrication techniques.  However, few studies have been successful 
with 3D cardiac constructs due to the incredible complexity and difficulties that are 
involved.   
 The main objective of the current project was to create highly organized cardiac 
tissue constructs using micropatterned CNT embedded GelMA hydrogels.  NIH 3T3-
fibroblasts were used for preliminary studies and ultraviolet (UV) optimization.  Neonatal 
rat ventricular cardiomyocytes (NRVMs) and cardiac fibroblasts were used as primary 
cell types within the native myocardium tissue and green fluorescent protein (GFP)-
expressing human umbilical vein endothelial cells (HUVECs) were used as primary cells 
for endothelium.  Three main aims of the project are shown in the Figure 1.   
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Figure 1. Three main objectives of the project. 
 
1. Bulk 3D cardiac constructs with CNT embedded GelMA hydrogels were created.  
2.  Using the CNT embedded GelMA hydrogels, micropatterned 3D cardiac 
constructs were to be created. 
3.  The mechanochemical and biophysiological properties, such as the cell adhesion, 
maturation, and alignment, phenotypic images of cardiac cells, mechanical 
integrity and electrophysiological functions were measured. 
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Due to time restrictions and project complexity that delayed the progress of the 
project, the results that are included in this study are limited to the bulk 3D cardiac 
constructs with NRVMs and results from the preliminary studies. 
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METHODS 
Materials 
The chemicals for gelatin methacrylate (GelMA) (Gelatin (Type A, 300 bloom 
from porcine skin) and methacrylic anhydride (MA), pretreatment of glass slides ((3- 
trimethoxysilyl) propyl methacrylate (TMSPMA) and polyethylene glycol diacrylate 
(PEGDA) were all purchased from SigmaeAldrich (Wisconsin, USA).  Glass slides and 
coverslips were purchased from Fisher Scientific (Pennsylvania, USA).  The 
photoinitiator, 2-hydroxy-1-(4-(hydroxyethoxy)-phenyl)-2-methyl-1-propanone (Irgacure 
2959) was purchased from CIBA Chemical.  Photolithography printed photomasks were 
purchased from CADart (Washington, USA), while the UV light source (Omnicure 
S2000) was purchased from EXFO Photonic Solutions Inc. (Ontario, Canada).  Digital 
calipers from Marathon Watch Company Ltd (Ontario, Canada) were used to determine 
the thickness of the spacers.  Carboxyl-functionalized multiwalled carbon nanotubes 
(diameters of 9±8 nm, lengths of 50-250 µm with 95% purity) from NanoLab Inc. were 
used as purchased.   
 
Gelatin methacrylate synthesis 
GelMA was synthesized by briefly adding porcine gelatin at 10% (w/v) into Dulbecco’s 
phosphate buffered saline (DPBS) at 50o and stirred until completely mixed.  Then, 0.8 
mL of MA were added per grams of gelatin and completely dissolved while stirring at 
50o for 2 hours.  In order to stop the methacrylation, the mixture was diluted with DPBS.  
The diluted mixture was subsequently dialyzed against distilled water using 12-14kDa 
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cutoff dialysis tubing for 1 week at 40 o to remove unreacted MA and salt.  The solution 
was lyophilized for 1 week. 
 
TMSPMA Treatment 
Glass slides (Fisher Scientific, USA) were placed in a glass container that 
contained fully dissolved 50g of sodium hydroxide (NaOH) and 450mL of distilled (DI) 
water.  The glass container was covered with a glass lid and the reaction was allowed to 
proceed overnight.  Each slide was thoroughly rinsed in distilled water and distinct 100% 
reagent alcohol afterwards and air dried.  The slides were stacked in a beaker vertically 
and 1.5mL of TMSPMA were poured on each end of the stack to ensure even coating, 
thus, a total of 3mL of TMSPMA was used.  The beaker containing TMSPMA treated 
slides were covered with aluminum foil and placed in an 80 o oven overnight.  
Afterwards, each slide was dipped in distinct 100% reagent alcohol and air dried 
completely.  The treated slides were tightly wrapped with aluminum foil to prevent any 
light exposures. 
 
PEGDA Coating 
The TMSPMA treated glass slides were coated with PEGDA (20%) with 5% PI to inhibit 
cell adhesion by UV exposure (7mW/cm2) for 50 seconds within 3 hours of use and 
placed in DPBS to prevent from drying. 
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Cell Isolation and Culture 
All cells were maintained in a standard cell culture incubator (Forma Scientific) in 
a 5% CO2-95% air atmosphere at 37 o.  NIH 3T3-fibroblasts were maintained in 
Dulbecco’s modified Eagle medium (DMEM, Gibco, USA) supplemented with 10% fetal 
bovine serum (FBS, Gibco, USA), 1% Penicillin/Streptomycin (P/S, Gibco, USA) and 
passaged every 3 days. 
Neonatal rat ventricular cardiomyocytes (NRVMs) were isolated from 2 day old 
Sprague-Dawley rats based on a well-established protocol approved by the Institute’s 
Committee on Animal Care.  Cardiomyocytes were used immediately after the isolation 
and enrichment through 1 hour of preplating.  The cardiac cells were seeded onto either 
GelMA or CNT-GelMA.  And the seeded samples were cultured in DMEM (Gibco, 
USA) with 10% FBS (Gibco, USA), 1% L-glutamine (Gibco, USA), and 100 units/mL of 
P/S (Gibco, USA) up to 7 days without electric field stimulation. 
Green fluorescent protein (GFP)-expressing human umbilical vein endothelial 
cells (HUVECs) were cultured in endothelial cells basal medium (EBM-2; Lonza) 
supplemented with endothelial growth BulletKit (EGM-2; Lonza), 2% FBS (Gibco, 
USA), vascular endothelial growth factor (VEGF), human fibroblast growth factor 
(hFGF), insulin growth factor (R3-IGF-I), human epidermal growth factor (hEGF), 
hydrocortisone, ascorbic acid, heparin, and 1% GA-1000 (gentamicin and amphotericin 
B). 
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Prepolymer Solutions Preparation 
GelMA was dissolved in DPBS (2% w/v) at 50o for 10 minutes and carboxyl acid 
group functionalized multiwalled CNTs (5mg/mL) were added to the solution.  In order 
to obtain a black ink-like solution containing GelMA-coated CNTs, the solution was then 
sonicated (VCX 400, 80W, 2 sec on and 1sec off) for 1 hours in a water bath.  Then, the 
selected amounts of the solution were added to a GelMA solution (5% w/v) with 0.25% 
or 0.5% PI to make prepolymer solutions of 0, 0.5, and 1mg/mL of CNTs. 
 
Cell Encapsulation and Micropatterning 
Appropriate cell types were trypsinized and resuspended in CNT-GelMA 
prepolymer solution containing either 0.5% or 0.25% of PI at various cell concentrations.  
And 3D cell-laden hydrogels (6mm in diameter, 150µm in height) with 5 or 7% GelMA, 
0.5mg/mL CNT-GelMA, and 1mg/mL CNT-GelMA were fabricated by exposure to 7 
mW/cm2 UV light for indicated amounts of time. 
 
Statistical Analysis 
Statistical significance was measured by an independent Student t-test and a one-
way or two-way analysis of variance (ANOVA) using SPSS statistical software package.  
Data are represented as mean±standard deviation (SD) and the differences were reported 
as significant when p < 0.05. 
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RESULTS 
 
 Biomaterials for cell-laden hydrogels have been generally prepared in DPBS or 
media.  CNTs were uniformly dispersed in DPBS when coated with GelMA and the 
patterning of GelMA enabled homogenous dispersion of CNTs in GelMA prepolymer 
solutions.  Micropatterns of CNT-GelMA hybrid hydrogels were well-formed throughout 
the constructs and 3T3 cells were encapsulated within the channels at day 0 and 
elongated along the channels (Figure 2).   
 
Figure 2. The formations of channels in CNT-GelMA hydrogels with 3T3 cells 
(5×106 cells/mL) and 75µm/75µm channel/space photomask. (a) The channels 
observed at day 0, (b) day 1, and (c) day 4 in 5% GelMA with UV exposure of 60s (10X). 
(d) The channels observed at day 0, (e) day 1, (f) day 4 in 0.5mg/mL CNT in 5% GelMA 
with UV exposure of 85s (10X). (g) The channels formed in 1mg/mL CNT in 5% GelMA 
at day 0, (h) day 1, (i) day 4 with UV exposure of 105s (10X). 
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 The height of the channels created by a 75µm/75µm channel/space photomask 
and a 100µm spacer remained consistent in all CNT-GelMA hydrogels (Figures 3&4). 
 
 
 
 
 
Figure 3. The height measurements of the channels in CNT-GelMA hydrogels using 
a 75µm/75µm channel/space photomask. The sagittal section of the channels that 
shows their height (a) 4X, (b) 10X in 5% GelMA with UV exposure of 60s; (c) 4X, (d) 
10X in 0.5mg/mL CNT in 5% GelMA with UV exposure of 85s; and (e) 4X, (f) 10X in 
1mg/mL CNT in 5% GelMA with UV exposure of 105s. 
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Figure 4. The calculated average height of the channels in CNT-GelMA hybrid 
hydrogels using a 75µm/75µm channel/space photomask. 
 
 
	  
	  
 Cell adhesion, viability, proliferation, and organization in CNT-GelMA hybrid 
hydrogels and pristine GelMA hydrogels were observed and evaluated.  More cells were 
observed along the micropatterns in CNT-GelMA hybrid hydrogels, compared to GelMA 
hydrogels (Figures 5a,d,g).   
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Figure 5. Improvement of 3T3 cells adhesion, maturation, and alignment on CNT-
GelMA. (0.5% PI and 75µm/75µm channel/space photomask) The image of 3T3 cells 
retention and homogeneity of seeding on (a) 5% GelMA with UV exposure of 60s, (d) 
0.5mg/mL CNT in 5% GelMA with UV exposure of 85s, and (g) 1mg/mL CNT in 5% 
GelMA with UV exposure of 105s at day 1 (10X). The viability of the 3T3 were 
determined by staining with (b),(e),(h) Calcein AM (green; live cells) and (c),(f),(i) 
propidium iodide (red; dead cells) at day 1. 
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 Bulk 3D cardiac constructs with CNT embedded GelMA hydrogels were 
successfully created using neonatal rat ventricular cardiomyocytes (Figure 6).  And the 
spontaneous beating rates of cardiac tissues were significantly higher in constructs with 
CNT, compared to without CNT.  Additionally, the beating behaviors were not observed 
until day 6 of the encapsulation and the constructs continue to beat up to day 24. 
 Since the incorporation of CNTs into 5% GelMA leads to enhanced mechanical 
properties of GelMA hydrogels while preserving their porosity and biodegradability, the 
concentration of GelMA was increased to 7% to observe its effect on the formation of 
channels using 3T3 cells(Figures 7,8,9).  The micropatterns were well-formed and the 
3T3 cells were well encapsulated within the channels. 
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Figure 6. Improvement of mechanical integrity of the cardiomyocytes on CNT-
GelMA. The videos show the spontaneous beating of cardiomyocytes on (a) 5% GelMA 
with UV exposure of 12s, (b) 0.5mg/mL CNT with UV exposure of 25s and (c) 1mg/mL 
CNT with UV exposure of 40s with 0.5% PI at day 12.  The spontaneous beating 
behaviors were also recorded at day 24 for 3D bulk cardiac constructs in (d) 5% GelMA, 
(e) 0.5mg/mL CNT-GelMA hybrid hydrogels, and (f) 1mg/mL CNT-GelMA hybrid 
hydrogels. 
 
 Since the incorporation of CNTs into 5% GelMA leads to enhanced mechanical 
properties of GelMA hydrogels while preserving their porosity and biodegradability, the 
concentration of GelMA was increased to 7% to observe its effect on the formation of 
channels using 3T3 cells (Figures 7,8,9).  The micropatterns were well-formed and the 
3T3 cells were well encapsulated within the channels. 
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Figure 7. Phase contrast images showing the good formations of micropatterns and 
cell elongation within the channels in 7% GelMA hydrogels at day 1 and day 3.  
(a),(b) The channels encapsulated with 3T3 cells in 7% GelMA at day 1 and (c),(d) day 3 
with UV exposure of 15s (10X) and 50µm/100µm channel/space photomask. 
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Figure 8. Phase contrast images showing the good formations of micropatterns and 
cell elongation within the channels in 0.5mg/mL CNT-GelMA hydrogels at day 1 
and day 3. (a),(b) The channels encapsulated with 3T3 cells in 0.5mg/mL CNT in 7% 
GelMA at day 1 and (c),(d) day 3 with UV exposure of 20s (10X) and 50µm/100µm 
channel/space photomask. 
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Figure 9. Phase contrast images showing the good formations of micropatterns and 
cell elongation within the channels in 1mg/mL CNT-GelMA hydrogels at day 1 and 
day 3. (a),(b) The channels encapsulated with 3T3 cells in 1mg/mL CNT in 7% GelMA 
at day 1 and (c),(d) day 3 with UV exposure of 25s (10X) and 50µm/100µm 
channel/space photomask. 
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Although the micropatterns were observed, the encapsulation of cardiomyocytes 
was not as successful as was with 3T3 cells.  Even at day 3, only a few of the cells were 
elongated and significant aggregations were observed with cells in CNT-GelMA hybrid 
hydrogels (Figures 10, 11, 12). 
 
 
 
Figure 10. Phase contrast images showing some formations of micropatterns and 
cell elongation within the channels in 7% GelMA hydrogels at day 1 and day 3. 
(a),(b) The channels encapsulated with cardiomyocytes in 7% GelMA at day 1 and (c),(d) 
day 3 with UV exposure of 15s (10X) and 50µm/100µm channel/space photomask 
 
 
 
 
    
 
24 
 
 
 
 
 
 
 
 
Figure 11. Phase contrast images showing some formations of micropatterns and 
cell elongation within the channels with clearly visible aggregates 0.5mg/mL CNT-
GelMA hybrid hydrogels at day 1 and day 3. (a),(b) The channels encapsulated with 
cardiomyocytes in 0.5mg/mL CNT in 7% GelMA at day 1 and (c),(d) day 3 with UV 
exposure of 20s (10X) and 50µm/100µm channel/space photomask. 
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Figure 12. Phase contrast images showing some formations of micropatterns and 
cell elongation within the channels with significantly aggregated cardiomyocytes in 
1mg/mL CNT-GelMA hybrid hydrogels at day 1 and day 3. (a),(b) The channels 
encapsulated with cardiomyocytes in 1mg/mL CNT in 7% GelMA at day 1 and (c),(d) 
day 3 with UV exposure of 25s (10X) and 50µm/100µm channel/space photomask. 
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 In order to evaluate mechanical integrity of the 3D cardiac constructs in CNT-
GelMA hybrid hydrogels, the spontaneous beating behaviors were observed.  All tissues 
showed spontaneous synchronous beating activity from day 3 and the spontaneous 
beating rates were recorded and plotted from day 3 to day 7 (Figure 13).  By day 5, 3D 
cardiac tissues in CNT-GelMA showed a more stable spontaneous beating behavior with 
significantly higher spontaneous beating rates (59.8±18.7 BPM and 63.2±28.4 BPM 
0.5mg/mL CNT and 1mg/mL CNT, accordingly), compared to those in pristine GelMA 
hydrogels. 
 
 
Figure 13.  Spontaneous beating rates of 3D cardiac constructs in CNT-GelMA and 
7% GelMA hydrogels. 
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 A different approach to generate micropatterned 3D cardiac constructs was 
suggested and the mixture of cardiomyocytes (5×106 cells/mL) and cardiac fibroblasts 
(5×106 cells/mL) with the total concentration of 10×106 cells/mL was resuspended in 
prepolymer solutions (Figure 14).  In order to ensure that the micropatterns are well-
formed and the cells are encapsulated within the channels, the height of the spacers was 
lowered from 150µm to 100µm.  The micropatterns were clearly visible throughout the 
3D constructs in all hydrogels at day 1 (Figures 14a,b,c) and the cells were elongated 
along the wall of the channels and started to degrade the hydrogels at day 5 (Figures 
14d,e,f). 
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Figure 14. Phase contrast images presenting good formation of the micropatterns 
and cell elongation along the channels in all hydrogels at day 1 and day 5 with 
cardiomyocytes (5×106 cells/mL) and cardiac fibroblasts (5×106 cells/mL). (10X). 
The channels were encapsulated with cardiomyocytes and cardiac fibroblasts in (a) 7% 
GelMA, (b) 0.5mg/mL CNT in 7% GelMA, and (c) 1mg/mL CNT in 7% GelMA with 
UV exposure of 20s, 25s, and 30s accordingly.  By day 5, cells in (d) 7% GelMA, (e) 
0.5mg/mL CNT in 7% GelMA, and (f) 1mg/mL CNT in 7% GelMA have been elongated 
within the channels.  50µm/100µm channel/space photomask and 100 µm spacers were 
used for cell encapsulation. 
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 The 3D cardiac scaffolds in CNT-GelMA hybrid hydrogels with the 
combination of cardiomyocytes (7.5×106 cells/mL) and cardiac fibroblasts (7.5×106 
cells/mL) showed good micropatterns throughout the constructs at day 0, while no visible 
micropatterns were observed in 3D cardiac constructs in pristine 7% GelMA.  Also, the 
data was inconsistent as considerably higher concentration of cells was encapsulated in 
0.5mg/mL CNT in 7% GelMA, compared to 1mg/mL CNT in 7% GelMA.  Furthermore, 
the 3D constructs in CNT-GelMA became detached at day 1 without any spontaneous 
beating activity. 
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Figure 15. Phase contrast images presenting good formation of the micropatterns in 
CNT-GelMA hybrid hydrogels with increased concentration of the cells (7.5×106 
cells/mL, each) and height of the spacers (150µm). (a) 10X, (b) 4X; The channels 
encapsulated with cardiomyocytes and cardiac fibroblasts in 0.5mg/mL CNT in 7% 
GelMA with UV exposure of 20s and (c) 10X,(d) 4X; the cardiac fibroblasts were 
encapsulated in 1mg/mL CNT in 7% GelMA with UV exposure of 25s (10X) and 
50µm/100µm channel/space photomask. 
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DISCUSSION 
The cross-linking between CNTs in GelMA matrix led to the formation of 
continuous fractal-like nanofibrous networks that showed homogeneous dispersion 
throughout the macroporous hydrogel (Shin et al., 2013).  And the micropatterning of 
CNT-GelMA hybrid hydrogels with PEGDA coating allowed the cells to be encapsulated 
within the channels and elongate along the channel wall (Figure 2).  Since the cardiac 
constructs are three-dimensional and the cells are encapsulated within the channels, the 
height of the micropatterns is crucial.  When the heights of the channels were measured, 
they remained consistently high as the thickness of the spacer in all CNT-GelMA 
hydrogels (Figure 4). 
 Cardiomyocytes seeded on CNT-GelMA substrates showed significantly higher 
cell viability, adhesion, uniformity, and organization of engineered cardiac tissue, 
compared to the GelMA (Shin et al., 2013).  Also, no cytotoxic effects of CNTs were 
observed up to day 7 of the culture (Shin et al., 2013).  The improved viability, adhesion, 
and organization of cardiomyocytes on CNT-GelMA thin films observed was due to the 
CNT nanofibrous networks and their architectural similarity to the ECM (Shin et al., 
2013).  Along with their already known mechanical and electrophysiological properties 
and biocompatibility, the CNT-GelMA hybrid hydrogels seemed appropriate as 3D 
constructs, since higher concentration of cells was observed along the micropatterns in 
CNT-GelMA hybrid hydrogels, compared to those in GelMA hydrogels (Figure 5). 
 As anticipated, bulk 3D cardiac constructs with CNT-GelMA hybrid hydrogels 
exhibited higher spontaneous beating rates, compared to those in pristine GelMA 
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hydrogels.  The tissues on CNT-GelMA were intact, while ruptured cardiac tissues were 
observed in GelMA on day 12 (Figures 6a,b,c).  However, severed pieces of tissues were 
observed in all tissues by day 24 (Figures 6d,e,f).  Also, the beating behaviors were not 
observed until day 6 of the encapsulation in all tissues and the constructs continued to 
beat up to day 24.  The starting time of the beating behaviors of bulk 3D constructs raised 
an issue, since all 2D cardiac tissues with cardiomyocytes seeded on CNT-GelMA or 
pristine GelMA showed spontaneous synchronous beating behaviors after day 1 (Shin et 
al., 2013). 
 The disordered polypeptide chains of the GelMA during the sonication process 
for the preparation of CNT-GelMA prepolymer solutions reorients on the CNT surface 
through hydrophobic interactions (Shin et al., 2012).  GelMA can effectively coat and 
separate CNTs by the interactions of its hydrophilic segments with water and the contacts 
between the hydrophobic regions of its polypeptide chain with CNTs (Shin et al., 2012).  
The GelMA coated CNT enhances the mechanical properties of CNT-GelMA hybrid 
hydrogels by increasing the solubility of CNTs in DPBS and providing large numbers of 
acrylic groups on CNT surfaces (Shin et al., 2012)  Thus, the concentration of GelMA 
was increased from 5% to 7% and cells were encapsulated inside the hybrid hydrogels 
(Figures 7,8.9).  Also, the concentration of cells being resuspended was increased from 
5×106 cells/mL to 70×106 cells/mL to ensure enough cells to be encapsulated for 
spontaneous beating behaviors.  Even with more than 10 folds of increase in cell 
concentration, 3T3 cells in all hydrogels were well encapsulated within the channels and 
elongated along the channel wall (Figures 7,8,9).  However, cardiomyocytes were not 
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encapsulated as successfully with repeated experiments in exact conditions (Figures 
10,11,12).  Even at day 3, limited numbers of elongated cells were observed in pristine 
GelMA (Figure 10).  Although higher number of cells were encapsulated in CNT-GelMA 
hybrid hydrogels, compared to those in GelMA hydrogels, substantial amounts of 
aggregations were also noted (Figures 11, 12).  It was previously studied that growth of 
the cells encapsulated in the CNT-GelMA hybrid hydrogels was supported with higher 
proliferation rates than those in the GelMA hydrogels (Behan et al., 2011; Shin et al., 
2012).   
 Electrophysiological properties of the micropatterned 3D cardiac constructs in 
CNT-GelMA hybrid hydrogels were measured by observing the spontaneous beating 
behaviors.  All tissues showed spontaneous synchronous beating activity from day 3 
(Figure 13), which still took 24-48 hours longer than the 2D cardiac tissue based on 
CNT-GelMA thin films despite its high cell concentration (Shin et al., 2013).  However, 
due to the thickness differences and other interactions between the 3D constructs and 2D 
constructs, it was expected for the 3D constructs to exhibit delayed spontaneous 
synchronous beating behaviors.  Cardiac tissues in CNT-GelMA hybrid hydrogels 
showed a more stable spontaneous behavior with higher beating rates, compared to 
cardiac tissues in GelMA hydrogels (Figure 13).  Although the micropatterned 3D 
cardiac tissues in CNT-GelMA presented spontaneous synchronous beating behaviors 
considerably sooner than the bulk 3D cardiac tissues in CNT-GelMA (Figure 6), the 
cardiac tissues were detached from the TMSPMA coated slides by day 5 with additional 
PEG coating.  The coating of TMSPMA on glass slides was controlled to weaken the 
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bonding between the 2D CNT-GelMA hybrid hydrogels based cardiac films so that the 
2D patches can be naturally released after 7 days of culturing (Shin et al., 2013).  And 
especially with significantly higher concentration of cell, the spontaneous synchronous 
beating behaviors within the 3D cardiac tissues may have been too strong for them to be 
stay attached to the TMSPMA coated slides for more than 5 days.  Because the 
micropatterned 3D cardiac constructs in CNT-GelMA hybrid hydrogels shows the 
synchronous beating behaviors from the day 3, the duration of the recording time was 
determined to be insufficient. 
 There are many different cell types in the myocardium.  While cardiomyocytes 
that represent nearly one-third of them are responsible for synchronous contractions of 
the ventricles, most of the non-myocytes are cardiac fibroblasts that play a significant 
role in structural, biochemical, mechanical, and electrical properties of the myocardium 
(Radisic et al., 2007).  Moreover, cardiac fibroblasts can affect adjacent cardiomyocytes 
by the coupling of gap junctions and secretion of regulatory molecules and ECM 
components (Camelliti et al., 2005; Gaudesius et al., 2003; Kohl, 2003; Radisic et al., 
2007; Rudy, 2004; Sussman et al., 2002;).  Thus, the composition of myocardial ECM is 
controlled by interactions between cardiomyocytes and cardiac fibroblasts (Radisic et al., 
2007; Sussman et al., 2002).   
 In order to improve the cell integrity when encapsulated, both cardiomyocytes 
(5×106 cells/mL) and cardiac fibroblasts (5×106 cells/mL) were mixed and resuspended 
in hydrogels (Figure 14).  It was previously found that pre-treated synthetic elastomeric 
scaffolds with cardiac fibroblasts enhance the functionality of the engineered cardiac 
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constructs by improving cardiomyocyte attachment and function (Radisic et al., 2007).  
In order to ensure that the micropatterns are well-formed and the cells are encapsulated 
within the channels, the height of the spacers was lowered from 150µm to 100µm.  The 
micropatterns were clearly visible throughout the 3D constructs in all hydrogels at day 1 
(Figures 14a,b,c) and the cells were elongated along the wall of the channels and started 
to degrade the hydrogels at day 5 (Figures 14d,e,f).  However due to lowered spacers, the 
cells more closely appeared to be encapsulated in 2D constructs rather than the intended 
3D constructs.  When the mixture of cardiomyocytes (7.5×106 cells/mL) and cardiac 
fibroblasts (7.5×106 cells/mL) with the total concentration of 15×106 cells/mL were 
resuspended in prepolymer solutions (Figure 14).  Even though the combination of 
cardiomyocytes and cardiac fibroblasts in both pristine 7% GelMA hydrogels and CNT-
GelMA hybrid hydrogels showed great patterns and well-encapsulated within the 
channels at day 0, the cardiac constructs became detached at day 1 and they could not be 
observed or recorded afterwards. 
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CONCLUSIONS	  
 
 CNTs were successfully dispersed in DPBS when coated with GelMA and the 
patterning of GelMA enabled homogenous dispersion of CNTs in GelMA prepolymer 
solutions.  Also, photopatterning of CNT-GelMA hybrid hydrogel with controllable 
dimensions and shapes was demonstrated.  The majority of the encapsulated cells in the 
CNT-GelMA hybrid hydrogels were viable and the mechanical properties of CNT-
GelMA hybrid hydrogels were maintained even with higher concentration of GelMA. 
 It was demonstrated that the engineered cardiac tissue constructs in CNT 
embedded in GelMA hydrogels showed promising mechanical and electrophysiological 
properties.  The 3D cardiac constructs in CNT-GelMA hybrid hydrogels showed 
significantly higher spontaneous synchronous beating rates with more stable spontaneous 
beating behavior, compared to those in GelMA hydrogels.  Moreover, enhanced cell 
adhesion and cell-cell coupling were observed within the micropatterned channels. 
 Additional studies are essential to thoroughly analyze the mechanical and 
electrophysiological properties of micropatterned 3D cardiac tissue constructs in CNT-
GelMA hybrid hydrogels.  If proven effective, 3D cardiac constructs in CNT-GelMA 
hybrid hydrogels may be used for in vitro studies and future therapeutic purposes. 
 
 
 
    
 
37 
 
LIST OF JOURNAL ABBREVIATIONS  
 
Am J Physiol Heart Circ Physiol American Journal of Physiology. Heart and 
Circulatory Physiology 
ACS Nano    American Chemical Society Nano 
Cardiovasc Res   Cardiovascular Research 
Circ Res    Circulation Research 
Crit Rev Biochem Mol Biol Critical reviews in biochemistry and molecular 
biology 
FASEB J    FASEB Journal 
J Am Chem Soc   Journal of the American Chemical Society 
J Biomed Mater Res   Journal of Biomedical Materials Research 
J Biomed Mater Res A  Journal of Biomedical Materials Research Part A 
J Chem Technol Biotechnol  Journal of Chemical Technology and Biotechnology 
Nat Biotechnol    Nature Biotechnology 
Proc Natl Acad Sci U S A Proceedings of the National Academy of Sciences 
of the United States of America 
    
 
38 
 
REFERENCES 
 
Aubin, H., Nichol, J.W., Hutson, C.B., Bae, H., Sieminski, A.L., Cropek, D.M., Akhyari, 
 P., Khademhosseini, A. (2010). Directed 3D cell alignment and elongation in 
 microengineered hydrogels. Biomaterials. 1-11. 
 
Behan, B.L., DeWitt, D.G., Bogdanowicz, D.R., Koppes, A.N., Bale, S.S., Thompson,  
D.M. (2011). Single-Walled Carbon Nanotubes Alter Schwann Cell Behavior 
Differentially within 2D and 3D Environments. J Biomed Mater Res. 96A: 46-57. 
 
Bienaime, C; Barbotin, J.N., Nava-Saucedo, J.E. (2003).  How to Build an Adapted and  
Bioactive Cell Microenvironment? A Chemical Interaction Study of the Structure 
of Ca-Alginate Matrices and their Repercussion on Confined Cells. J Biomed 
Mater Res. 67A: 376-388. 
 
Brigham, M.D., Bick, A., Lo, E., Bendali, A., Burdick, J.A., Khademhosseini, A. (2009). 
 Mechanically robust and bioadhesive collagen and photocrosslinkable hyaluronic 
 acid semi-interpenetrating networks. Tissue Engineering. 15A (7): 1645-1653. 
 
Bulte, J.W.M., Douglas, T., Witwer, B., Zhang, S.C., Strable, E., Lewis, B.K., et al. 
 (2001). Magnetodendrimers allow endosomal magnetic labeling and in vivo 
 tracking of stem cells. Nature Biotechnology. 19 (12): 1141-1147. 
 
Bulte, J.W.M., Zhang, S.C., van Gelderen, P., Herynek, V., Jordan, E.K., Duncan, I.D., et 
 al. (1999). Neurotransplantation of magnetically labelled oligodendrocyte 
 progenitors: magnetic resonance tracking of cell migration and myelination. Proc 
 Natl Acad Sci U S A. 96 (26): 15256-15261. 
 
Camelliti, P., Borg, T.K., Kohl, P. (2005). Structural and functional characterisation of  
cardiac fibroblasts. Cardiovasc Res. 65: 40-51. 
 
Cellot, G., Cilia, E., Cipollone, S., Rancic, V., Sucapane A., Giordani, S., Gambazzi, L., 
 Markram, H., Grandolfo, M., Scaini, D.F.G., Casalis, L., Prato, M., Giugliano,  
M., Ballerini, L. (2009). Carbon nanotubes might improve neuronal performance  
by favouring electrical shortcuts. Nature Nanotechnology. 4: 126-133. 
 
Chan, V., Raman, R., Cvetkovic, C., Bashir, R. (2013). Enabling Microscale and 
 Nanoscale Approaches for Bioengineered Cardiac Tissue. ACS Nano. 7 (3): 
 1830-1837. 
 
    
 
39 
 
Chen, R.J., Bangsaruntip, S., Drouvalakis, K.A., Kam, N.W.S., Shim, M., Li, Y., et al. 
 (2003). Noncovalent functionalization of carbon nanotubes for highly specific 
 electronic biosensors. Proc Natl Acad Sci U S A. 100 (9): 4984-4989. 
 
Chia, S.M., Leong, K.W., Li, J., Xu, X., Zeng, K.Y., Er, P.N., Gao, S.J., Yu, H. (2000)  
Hepatocyte Encapsulation for Enhanced Cellular Functions. Tissue Engineering. 
6: 481-494. 
 
Chien, K.R., Domian, I.J., Parker, K.K. (2008). Cardiogenesis and the Complex Biology 
 of Regenerative Cardiovascular Medicine. Science. 322: 1494-1497. 
 
Discher, D. E., Janmey, P., Wang, Y. I. (2005). Tissue Cells Feel and Respond to the 
 Stiffness of their Substrate. Science. 310: 1139-1143. 
 
Drury, J.L., Mooney, D.J. (2003). Hydrogels for Tissue Engineering: Scaffold Design  
Variables and Applications. Biomaterials. 24: 4337-4351. 
 
Du, Y., Lo, E., Ali, S., Khademhosseini, A. (2008). Directed assembly of cell-laden 
 microgels for fabrication of 3D tissue constructs. Proc Natl Acad Sci U S A.  
105 (28): 9522-9527. 
 
Engler, A. J., Sen, S., Sweeney, H. L. Discher, D. E. (2006). Matrix Elasticity Directs 
 Stem Cell Lineage Specification. Cell. 126: 677-689. 
 
Eschenhagen, T., Eder, A., Vollert, I., & Hansen, A. (2012). Physiological aspects of 
 cardiac tissue engineering. Am J Physiol Heart Circ Physiol. 303: H133-H143. 
 
Eschenhagen, T., Fink, C., Remmers, U., Scholz, H., Wattchow, J., Weil, J., Zimmerman, 
 W., Dohmen, H.H., Schafer, H., Bishopric, N., et al. (1997). Three-Dimensional 
 Reconstitution of Embryonic Cardiomyocytes in a Collagen Matrix: A New Heart 
 Muscle Model System. FASEB J. 11: 683-694. 
 
Furuta, A., Miyoshi, S., Itabashi, Y., Shimizu, T., Kira, S., Hayakawa, K., Nishiyama, N., 
 Tanimoto, K., Hagiwara, Y., Sataoh, T., et al. (2006). Pulsatile Cardiac Tissue 
 Grafts Using a Novel Three-Dimensional Cell Sheet Manipulation Technique 
 Functionally Integrates with the Host Heart in Vivo. Circ Res. 98: 705-712. 
 
Galis, Z.S., Khatri, J.J. (2002). Matrix metalloproteinases in vascular remodeling and 
 atherogenesis: the good, the bad, and the ugly. Circ Res. 90 (3): 251-62. 
 
Gaudesius, G., Miragoli, M., Thomas, S.P., Rohr, S. (2003). Coupling of cardiac  
electrical activity over extended distances by fibroblasts of cardiac origin. Circ 
Res. 93: 421-428. 
    
 
40 
 
Harrison, B.S., Atala, A. (2007). Carbon nanotube applications for tissue engineering. 
 Biomaterials. 28: 344-353. 
 
Hone, J., Kam, L. (2007). Nanobiotechnology: looking inside cell walls. Nature  
Nanotechnology. 2 (3): 140-141. 
 
Hutson, C.B., Nichol, J.W., Aubin, H., Bae, H., Yamanlar, S., Al-Haque, S., Koshy, S.T.,  
Khademhosseini, A. (2011). Synthesis and Characterization of Tunable 
Poly(ethylene glycol): Gelatin Methacrylate Composite Hydrogels. Tissue 
Engineering Part A. 17 (13-14): 1713-1723. 
 
Iijima, S. (1991). Helical microtubules of graphitic carbon. Nature. 354: 56-58. 
 
Khademhosseini, A., Eng, G., Yeh, J., Fukuda, J., Blumling, J III., Langer, R., Burdick,  
J.A. (2006). Micromolding of photocrosslinkable hyaluronic acid for cell 
 encapsulation and entrapment. J Biomed Mater Res A. 79 (3): 522-532. 
 
Kochanek, K.D., Xu, J.Q., Murphy, S.L., Meniño, A.M., Kung, H.C. (2011). Deaths:  
Final Data for 2009. National Vital Statistics Reports. 60 (3): 1-117. 
 
Kohl, P. (2003). Heterogeneous cell coupling in the heart: An electrophysiological role  
for fibroblasts. Circ Res. 93: 381-383. 
 
Kumachev, A., Greener, J., Tumarkin, E., Elser, E., Zandstra, P.W., Kumacheva, E.  
(2011). High-Throughput Generation of Hydrogel Microbeads with Varying 
Elasticity for Cell Encapsulation. Biomaterials. 32: 1477-1483. 
 
Langer, R., Vacanti, J.P. (1993). Tissue engineering. Science. 260 (5110): 920-926. 
 
Liau, B., Zhang, D., Bursac N. (2012). Functional cardiac tissue engineering. 
Regenerative Medicine. 7 (2): 187-206. 
 
Lutolf, M. P., Gilbert, P. M., Blau, H. M. (2009). Designing Materials to Direct Stem- 
Cell Fate. Nature. 462: 433-441. 
 
Mooney, E., Mackle, J. N., Blond, D.J.P., O’Cearbhaill, E., Shaw, G., Blau, W.J., Barry, 
 F.P., Barron, V., Murphy, J.M. (2012). The electrical stimulation of carbon 
 nanotubes to provide a cardiomimetic cue to MSCs. Biomaterials. 33: 6132-6139. 
 
Nichol, J.W., Koshy, S.T., Bae, H., Hwang, C.M., Yamanlar, S., Khademhosseini, Al. 
 (2010). Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials. 
 31: 5536-5544. 
 
    
 
41 
 
Park, J. S., Chu, J. S., Tsou, A. D., Diop, R., Tang, Z., Wang, A., Li, S. (2011). The effect  
of matrix stiffness on the differentiation of mesenchymal stem cells in response to 
TGF-β. Biomaterials. 32 (16): 3921-3930. 
 
Park, J.Y., Rosenblatt, S., Yaish, Y., Sazonova, V., Ustunel, H., Braig, S., Arias, T.A.,  
Brouwer, P.W., McEuen, P.L. (2004). Nano Letters. 4 (3): 517-520. 
 
Patel, P.N., Gobin, A.S., West, J.L., Patrick, C.W. (2005). Poly(ethylene glycol)  
Hydrogel System Supports Preadipocyte Viability, Adhesion, and Proliferation. 
Tissue Engineering. 11: 1498-1505. 
 
Peppas, N.A., Hilt, J.Z., Khademhosseini, A., Langer, R. (2006). Hydrogels in Biology  
and Medicine: From Molecular Principles to Bionanotechnology. Advanced 
Materials. 18 (11): 1345-1350. 
 
Radisic, M., Park, H., Martens, T.P., Salazar-Lazaro, J.E., Geng, W., Wang, Y., Langer,  
R., Freed, L.E., Vunjak-Novakovic, G. (2008). Pre-treatment of synthetic 
elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. J 
Biomed Mater Res A. 86: 713-724. 
 
Reynolds, C.H., Annan, N., Beshah, K., Huber, J.H., Shaber, S.H., Lenkinski, R.E., et al. 
 (2000). Gadolinium-loaded nanoparticles: new contrast agents for magnetic 
 resonance imaging. J Am Chem Soc. 122 (37): 8940-8945. 
 
Roger, V.L., Go, A.S., Lloyd-Jones, D.M., Benjamin, E.J., Berry, J.D., Borden, W.B., 
 Bravata, D.M., Dai, S., Ford, E.S., Fox, C.S., et al. (2012). Heart Disease and 
 Stroke Statistics-2012 Update: A Report From the American Heart Association 
 Statistics Committee and Stroke Statistics Subcommittee. Circ Res 117: e25. 
 
Rudy Y. (2004). Conductive bridges in cardiac tissue: A beneficial role or an  
arrhythmogenic substrate? Circ Res 94: 709-711. 
 
Shimizu, T., Yamato, M., Isoi, Y., Akutsu, T., Setomaru, T., Abe, K., Kikuchi, A.,  
Umezu, M., Okano, T. (2002). Fabrication of Pulsatile Cardiac Tissue Grafts  
Using a Novel 3-Dimensional Cell Sheet Manipulation Technique and  
Temperature-Responsive cell Culture Surfaces. (2002). Circ Res. 90: e40-e48. 
 
Shin, S.R., Bae, H., Cha, J.M., Mun, J.Y., Chen, Y.C., Tekin, H., Shin, H., Farshchi, S.,  
Dokmeci, M.R., Tang, S., Khademhosseini, A. (2012). Carbon Nanotube 
Reinforced Hybrid Microgels as Scaffold Materials for Cell Encapsulation. ACS 
Nano. 6 (1): 362-372. 
 
    
 
42 
 
Shin, S.R., Jung, S.M., Zalabany, M., Kim, K., Zorlutana, P., Kim, S.B., Nikkhah, M., 
 Khabiry, M., Khabiry, M., Azize, M., Kong, J., Wan, K., Palacios, T., Dokmeci, 
 M.R., Bae, H., Tang, X., Khademhosseini, A. (2013). Carbon-Nanotube-
 Embedded Hydrogel Sheets for Engineering Cardiac Constructs and Bioactuators. 
 ACS Nano. 7 (3): 2369-2380. 
 
Sussman, M.A., McCulloch, A., Borg, T.K. (2002). Dance band on the Titanic:  
Biomechanical signaling in cardiac hypertrophy. Circ Res. 91: 888-898. 
 
Tasis, D., Tagmatarchis, N., Bianco, A., Prato, M. (2006). Chemistry of carbon nanotube.  
Chem Rev. 106: 1105-1136. 
 
Tsang, V.L., Chen, A.A., Cho, L.M., Jadin, K.D., Sah, R.L., DeLong, S., et al. (2007). 
 Fabrication of 3D hepatic tissues by additive photopatterning of cellular 
 hydrogels. FASEB J. 21 (3): 790-801. 
 
Uludag, H., De Vos, P., Tresco, P.A. (2000). Technology of Mammalian Cell  
Encapsulation. Advanced Drug Delivery Reviews. 42 (1-2): 29-64. 
 
Van DenBulcke, A.I., Bogdanov, B., De Rooze, N., Schacht, E.H., Cornelissen, M., 
 Berghmans, H. (2000). Structural and rheological properties of methacrylamide 
 modified gelatin hydrogels. Biomacromolecules. 1 (1): 31-38. 
 
Van den Steen, P.E., Dubois, B., Nelissen, I., Rudd, P.M., Dwek, R.A., Opdenakker, G. 
 (2002). Biochemistry and molecular biology of gelatinase B or matrix 
 metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol. 37 (6): 375-536. 
 
Vunjak-Novakovic, G. (2006). Cardiac Tissue Engineering: Effects of Bioreactor Flow 
 Environment on Tissue Constructs. J Chem Technol Biotechnol. 81: 485-490. 
 
 
 
    
 
43 
 
VITA 
 
 
 
 
 
                           
 
 
 
 
 
 
  
   
  
 
 
  
 
   
  
  
 
 
  
 
   
   
  
 
   
   
 
 
 
 
   
    
    
  
  
  
    
 
44 
 
   
   
    
  
 
   
  
    
    
    
  
 
   
  
    
    
 
   
   
    
    
 
   
   
   
   
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
    
 
45 
 
    
   
     
 
 
 
 
      
 
   
         
      
 
    
    
  
  
 
 
 
  
 
 
   
   
  
 
  
 
 
 
 
    
    
    
    
     
    
 
 
